Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
株式のランク #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
株価
$0.00060315
最終同期: 2024-09-27
時価総額
$1.65M
変化(1日)
19.64%
変化(1年)
0.00%
SE
取引 Amniotics AB (publ) (AMNI)

カテゴリー

Amniotics AB (publ)(AMNI)の利益
Dec 2023 時点の利益 TTM: $-3.09M
Amniotics AB (publ) の最新の財務報告によると、同社の現在の利益は $-3.09M です。2022 年には $-4.61M の利益を上げ、これは 2021 年の利益 $-5.92M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Amniotics AB (publ) の利益の推移(2018 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $-3.09M 0.85%
2023 $-3.06M -33.59%
2022 $-4.61M -22.23%
2021 $-5.92M 57.96%
2020 $-3.75M 235.76%
2019 $-1.12M 45.50%
2018 $-767.77K 0.00%
同業他社の利益
企業 利益 利益の差
$5.27B -171,033.57%
US
$1.95B -63,310.98%
NL
- -
CH
- -
KR
$3.01B -97,500.51%
BE